DEFUSE 3 Non-DAWN Patients: A Closer Look at Late Window Thrombectomy Selection

BACKGROUND AND PURPOSE: DAWN and DEFUSE 3 established thrombectomy for patients with emergent large vessel occlusions (ELVO) presenting 6–24 hours after symptom onset. Given the greater inclusivity of DEFUSE 3 we evaluated the effect of thrombectomy in DEFUSE 3 patients who would have been excluded...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stroke
Autori principali: Leslie-Mazwi, Thabele M., Hamilton, Scott, Mlynash, Michael, Patel, Aman B., Schwamm, Lee H., Lansberg, Maarten G., Marks, Michael, Hirsch, Joshua A., Albers, Gregory W.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6768068/
https://ncbi.nlm.nih.gov/pubmed/30727856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.118.023310
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi